Newsroom

BIGBEAR Pharmaceutical announces the approval of Binimetinib and Encorafenib in Laos

Vientiane, Laos - October 12 2024 - BigBear Pharma, a leading biopharmaceutical

BIGBEAR Pharmaceutical announces the approval of Lusutrombopag in Laos

Vientiane, Laos - August 08 2024 - BigBear Pharma, a leading biopharmaceutical c

Double "zero" breakthrough! Laos BIGBEAR Pharmaceutical's anti-cancer drugs are exported to ASEAN economies fo

September 24, 2024 - Vientiane, Laos - Recently, Laos BIGBEAR Pharmaceutical ann

BIGBEAR Pharmaceutical announces the approval of Letermovir and Olaparib in Laos

Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutic

BIGBEAR Pharmaceutical announces the approval of Pralsetinib in Laos

Vientiane, Laos - August 12 2024 - BigBear Pharma, a leading biopharmaceutical c

BIGBEAR Pharmaceutical announces the approval of TAZEMETOSTAT in Laos

Vientiane, Laos - August 01 2024 - BigBear Pharma, a leading biopharmaceutical c

BIGBEAR Pharmaceutical announces the approval of Adagrasib in Laos

Vientiane, Laos - July 14, 2024 - BigBear Pharma, a leading biopharmaceutical co

BIGBEAR Pharmaceutical announces the approval of Larotrectinib in Laos

Vientiane, Laos - May 30, 2024 - BigBear Pharma, a leading biopharmaceutical com

BIGBEAR Pharmaceutical announces the approval of baricitinib and selumetinib in Laos

Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical co

Big Bear Pharmaceutical Announces Trelagliptin and Ivosidenib Approved in Laos

Laos Vientiane-January 03, 2024-BigBear Pharma, a leading alchemon company focus